Furthermore, specific knockdown of YAP1 and pharmacological inhibitor of YAP1 (verteporfin) inhibited the AATs expression and mTOR activation (phospho‐S6 and 4EBP1) in CRC cells and MEFs (Fig. 6F,G). This evidence concerns the gene YAP1 and colorectal carcinoma.